Can one afford not to screen for parasites in high-risk immigrant populations?

Clinical Infectious Diseases

Volumn 45, Issue 10, 2007, Pages 1316-1318

  Keystone, Jay S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ALBENDAZOLE; CORTICOSTEROID DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; IVERMECTIN; PRAZIQUANTEL; ANTHELMINTIC AGENT;

ABDOMINAL PAIN; BLOOD SAMPLING; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EOSINOPHILIA; FECES CULTURE; HELMINTHIASIS; HUMAN; IMMIGRATION; IMMUNOCOMPROMISED PATIENT; LABORATORY TEST; NOTE; PARASITE; PARASITOSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCHISTOSOMIASIS; SCREENING TEST; SEROLOGY; STRONGYLOIDIASIS; TREATMENT DURATION; VIRUS INFECTION; AGED; ANIMAL; CANADA; MASS SCREENING; MIDDLE AGED; MIGRATION;

AGED; AGED, 80 AND OVER; ANIMALS; ANTHELMINTICS; CANADA; EMIGRATION AND IMMIGRATION; HUMANS; MASS SCREENING; MIDDLE AGED; SCHISTOSOMIASIS; STRONGYLOIDIASIS;

EID: 36048960255     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/522530     Document Type: Note

References (23)

1. Posey DL Blackburn BG, Weinberg M, et al. High prevalence and presumptive treatment of schistosomiasis and strongyloidiasis among African refugees Clin Infect Dis 2007; 45:1310-5 (in this issue).
2. Gyorkos TW, Genta RM, Viens P, MacLean JD. Seroepidemiology of Strongyloides infection in the Southeast Asian refugee population in Canada. Am J Epidemiol 1990; 132:257-64.
3. Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001; 33:1040-7.
4. Sato Y, Kobayashi J, Toma H, Shiroma Y. Efficacy of stool examination for detection of Strongyloides infection. Am J Trop Med Hyg 1995; 53:248-50.
5. Seybolt LM, Christiansen D, Barnett ED. Diagnostic evaluation of newly arrived asymptomatic refugees with eosinophilia. Clin Infect Dis 2006; 42:363-7.
6. Nutman TB. Asymptomatic peripheral blood eosinophilia redux: common parasitic infections presenting frequently in refugees and immigrants. Clin Infect Dis 2006; 42:368-9.
7. Gill GV,Welch E, Bailey JW, Bell DR, Beeching NJ. Chronic Strongyloides stercoralis infection in former British Far East prisoners of war. QJM 2004; 97:789-95.
8. Gill GV, Beeching NJ, Khoo S, et al. A British Second World War veteran with disseminated strongyloidiasis. Trans R Soc Trop Med Hyg 2004; 98:382-6.
9. Loutfy MR, Wilson M, Keystone JS, Kain KC. Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a nonendemic area. Am J Trop Med Hyg 2002; 66: 749-52.
10. Treatment of Parasitic Diseases Medical Letter. August 2004.
11. Marti H, Haji HJ, Savioli L, et al. A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. Am J Trop Med Hyg 1996; 55:477-81.
12. Datry A, Hilmarsdottir I, Mayorga-Sagastume R, et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazole: results of an open study of 60 cases. Trans R Soc Trop Med Hyg 1994; 88:344-5.
13. Scowden EB, Schaffner W, Stone WJ. Overwhelming strongyloidiasis: an unappreciated opportunistic infection. Medicine (Baltimore) 1978; 57:527-44.
14. Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 2004; 17:208-17.
15. Lim S, Katz K, Krajden S, Fuksa M, Keystone JS, Kain KC. Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ 2004; 171: 479-84.
16. Schaeffer MW, Buell JF, Gupta M, Conway GD, Akhter SA,Wagoner LE. Strongyloides hyperinfection syndrome after heart transplantation: case report and review of the literature. J Heart Lung Transplant 2004; 23:905-11.
17. Viney ME, Brown M, Omoding NE, et al.Why does HIV infection not lead to disseminated strongyloidiasis? J Infect Dis 2004; 190: 2175-80.
18. Pacanowski J, Santos MD, Roux A, et al. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. Am J Trop Med Hyg 2005; 73:122.
19. Turner SA, Maclean JD, Fleckenstein L, Greenaway C. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis. Am J Trop Med Hyg 2005; 73: 911-4.
20. Marty FM, Lowry CM, Rodriguez M, et al. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis 2005; 41: e5-8.
21. Tarr PE, Miele PS, Peregoy KS, et al. Case report: rectal administration of ivermectin to a patient with Strongyloides hyperinfection syndrome. Am J Trop Med Hyg 2003; 68:453.
22. Levi GC, Kallas EG, Ramos Moreira Leite K. Disseminated Strongyloides stercoralis infection in an AIDS patient: the role of suppressive-therapy. Braz J Infect Dis 1997; 1:48-51.
23. Boulware DR, Stauffer WM, Hendel-Paterson BR, et al. Maltreatment of Strongyloides infection: case series and worldwide physicians-in-training survey. Am J Med 2007; 120:545.